Past events:
The LSE Summit: Rethinking regulation and value assessment of medical technologies: challenges and opportunities
8-9 March 2016, London
First Advance-HTA Capacity Building Workshop for Latin America
November 6 - 7 2014, Mexico City
Advance-HTA: Capacity building workshop
25-26 September 2014, Warsaw
The LSE Summit: Risk Sharing and Managed Entry Agreements
14 February 2014, London
LSE Health and Social Care public lecture: Innovation and Beyond in Healthcare
13 November 2012
Healthcare Policy Deciders Forum 2011
17 & 18 February 2011
Latest publications:
Kanavos P, Tinelli M, Efthymiadou O, Visintin E, Grimaccia F and Mossman J. Towards better outcomes in multiple sclerosis by addressing policy change: The International MultiPlE Sclerosis Study - IMPrESS. LSE. 2016
Kanavos P, Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States, Health Policy. 2014 Nov;118(2):229-41. doi: 10.1016/j.healthpol.2014.08.005. Epub 2014 Aug 27.
Ferrario, Alessandra and Kanavos, Panos (2015) Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Social Science and Medicine, 124 . pp. 39-47. ISSN 0277-9536
Kanavos P, Angelis A. Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?, Pharmaceut Med. 2014;28(5):245-248.
Yesudian CAK, Grepstad M, Visintin E and Ferrario A, The economic burden of diabetes in India: a review of the literature, Globalization and Health 2014, 10:80